Organic Acids (Urine): How Nutrition and Fasting Change Your Results

A urinary organic acids test (sometimes called an OAT test) measures dozens of small carbon-based metabolites that reflect mitochondrial function, B-vitamin adequacy, fatty-acid oxidation, and gut microbial activity. The Genova Diagnostics Organix panel is one commercial version of this test, run by gas chromatography-mass spectrometry (GC-MS) on a first-morning urine sample. The same test format is also used clinically, outside the functional-medicine context, to help evaluate suspected inborn errors of metabolism, usually in infants or children with acute metabolic symptoms.

The core point of this page: many of the analytes on an organic acids panel change meaningfully with what you ate, how long you fasted, and whether you were ketogenic, in ways large enough to mimic a genuine enzyme defect. A single abnormal value collected without attention to diet and fasting window is not, by itself, evidence of a metabolic disorder. Whether a result is a temporary dietary artifact or a persistent biochemical problem is decided by repeating the test under a standardized protocol and watching whether the abnormality resolves.

This distinction matters more than any single reference range, and it is the question this page is built to help you answer.

What the test is actually measuring

Organic acids are intermediates of pathways such as glycolysis, the TCA (Krebs) cycle, fatty-acid oxidation, amino acid catabolism, and neurotransmitter breakdown. When an enzyme or cofactor in one of these pathways is insufficient, the substrate upstream of the block can spill from blood into urine at detectable concentrations. Results are reported per milligram of creatinine to correct for how concentrated or dilute the urine sample is; without that correction, a dilute afternoon sample would read falsely low on nearly every marker compared with a first-morning void.

GC-MS remains the standard method for this panel. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is increasingly used for a handful of specific analytes, such as methylmalonic acid, where it offers better specificity, but GC-MS is what most commercial organic acid panels, including Genova's, still rely on for the broad screen.

Does fasting length change the results? Yes, and the direction matters

Fasting state is probably the single largest pre-analytical variable in this test.

Short fast (under 8 hours). Testing soon after a meal keeps glycolytic flux high, so pyruvate, lactate, and TCA-cycle intermediates like citrate can run elevated. This pattern can superficially resemble a pyruvate-handling disorder even in someone with normal metabolism.

Extended fast (well beyond 12 to 14 hours). As fasting lengthens, fat becomes the dominant fuel and fatty-acid oxidation intermediates rise: 3-hydroxybutyrate, acetoacetate, and dicarboxylic acids such as adipic and sebacic acid. This is a normal physiologic ketogenic shift, but it can overlap in appearance with fatty-acid oxidation disorders such as MCAD deficiency on a single unexplained readout.

The commonly recommended window is 10 to 12 hours, collected as a first-morning void, which keeps glycolytic markers near baseline while avoiding the ketogenic shift of a longer fast. This is a widely used clinical laboratory convention rather than a single randomized trial finding, and clinicians should verify the exact fasting window recommended by the specific reference lab being used, since protocols vary slightly between institutions.

How diet composition leaves a biochemical signature

Beyond fasting length, the pattern of eating over the prior two to three days shifts several markers.

High-carbohydrate intake increases flux through pyruvate dehydrogenase and can raise urinary citrate and related TCA intermediates as excess acetyl-CoA is exported for lipogenesis. High-sugar intake is also associated with elevated arabinose and tartaric acid on some panels, markers that vendors often label as yeast or microbial fermentation byproducts.

Ketogenic or very-low-carbohydrate diets substantially raise 3-hydroxybutyrate, acetoacetate, and dicarboxylic acids, sometimes by several-fold over a fed baseline. Reported without dietary context, this pattern can look like a fatty-acid oxidation defect. Anyone testing while eating ketogenically should note that explicitly on the lab requisition, and clinicians should discount an isolated dicarboxylic-acid elevation in that setting unless it is unusually severe or accompanied by other red flags.

High protein and branched-chain amino acid intake increase alpha-keto acid metabolites of leucine, isoleucine, and valine. Excess leucine breakdown also raises 3-hydroxyisovalerate, which is sometimes used as a functional biotin marker; the same elevation can occur from a high-leucine diet in someone who is biotin-replete, so this marker is not specific on its own.

Alcohol shifts the cytoplasmic NADH/NAD+ ratio, which slows the malate-aspartate shuttle. This raises urinary lactate and lowers pyruvate, and can push the lactate-to-pyruvate ratio well above the usual upper limit, mimicking mitochondrial dysfunction. Any alcohol intake within roughly 48 hours of collection should be treated as disqualifying for TCA-cycle interpretation.

Precise fold-changes and percentage shifts for these effects appear in the nutrition-and-metabolism literature, but the specific figures attached to earlier versions of this article could not be verified against a confirmed source and have been removed rather than repeated as exact numbers. Treat the directions above (which marker goes up, which goes down) as reasonably well established, and treat any specific percentage as something to confirm against the primary literature before quoting it to a patient.

B-vitamin functional markers: what is well supported

Three organic acid markers have a longer track record as functional indicators of vitamin cofactor status, though the strength of evidence differs by marker.

• Methylmalonic acid (MMA) and vitamin B12. MMA accumulates when adenosylcobalamin is insufficient for methylmalonyl-CoA mutase activity. Urinary and serum MMA are established functional markers of B12 status and can be abnormal even when serum B12 itself is in the normal range, which is why many clinicians treat MMA as more sensitive than serum B12 alone for detecting tissue-level deficiency. Supplementation with oral B12 typically normalizes MMA over a period of weeks, though the exact timeline is patient-dependent.
• Xanthurenic acid and vitamin B6. When B6 (pyridoxal-5-phosphate) is inadequate, tryptophan catabolism shunts toward xanthurenic acid instead of the normal pathway. Elevated xanthurenic acid is a recognized functional marker of B6 depletion, though it is also influenced by dietary tryptophan intake independent of B6 status.
• Formiminoglutamic acid (FIGLU) and folate. FIGLU accumulates when histidine catabolism stalls due to insufficient tetrahydrofolate, and has long been used as a functional folate marker, sometimes abnormal even when serum folate reads low-normal.

The general direction and biochemical logic of all three markers is well established in metabolic biochemistry. The specific numeric thresholds and exact normalization timelines cited in earlier drafts of consumer-facing material on this topic vary by laboratory and were not independently verifiable here; a clinician ordering these tests should rely on the performing lab's own reference interval and interpretive notes rather than a generic percentage.

Decision framework: is this abnormal result diet, timing, or something to investigate

Use this table as a first pass before assuming an abnormal organic acid result reflects a fixed metabolic disorder. It is a practical interpretive aid, not a diagnostic algorithm, and it does not replace review by the ordering clinician.

If an abnormal marker does not resolve after correcting the obvious dietary or fasting confounder, that is the point at which further clinical workup, rather than repeated dietary adjustment, becomes appropriate.

Normal ranges versus "optimal" ranges: a real but limited distinction

Standard laboratory reference ranges are built from a large population of specimens and typically represent roughly the 2.5th to 97.5th percentile of that population, stratified by age. Genova's Organix panel, for example, reports separate pediatric and adult ranges because metabolism differs substantially by age.

Functional medicine practice sometimes uses narrower "optimal" targets, for instance a lower ceiling for MMA than the laboratory's own upper limit of normal, or a preference for the middle of the reference range for TCA-cycle intermediates. This approach is a professional interpretive convention, not an FDA-recognized or clinical-guideline-endorsed reference standard. It can be a reasonable framework for individualized tracking, but it should not be presented to a patient as an established diagnostic cutoff, and a specific number below which someone is told they have a clinical problem should be treated with real caution unless it comes from the performing laboratory's own validated interval.

Gut microbial markers deserve extra caution

Hippuric acid, indican, arabinose, tartaric acid, and tricarballylic acid are influenced by gut bacterial and fungal metabolism as well as by diet. High dietary polyphenol intake (coffee, tea, berries) raises hippuric acid through normal microbial metabolism, and this is not a sign of dysfunction. Raw, unfermented, high-citrate foods such as citrus, uncooked tomato, and raw spinach can raise tricarballylic acid independent of any overgrowth.

Arabinose and tartaric acid are often marketed as candida or dysbiosis markers. This is a genuine gap in the evidence: there is no well-established clinical trial data confirming that urinary levels of these compounds reliably diagnose candida or Saccharomyces overgrowth, or that a low-sugar preparation diet meaningfully reduces false positives. Treat any interpretation built on these two markers as provisional and secondary to symptoms and other testing, not as a stand-alone diagnosis.

Collection protocol that reduces avoidable noise

1. Eat a normal, mixed, moderate-carbohydrate diet for about three days before testing. Avoid a strict ketogenic pattern, fasting beyond the recommended window, and unusually high-sugar meals.
2. Avoid alcohol for roughly 48 hours before collection.
3. Avoid high-dose biotin supplements (several milligrams per day or more) for at least 72 hours beforehand, since supraphysiologic biotin can interfere with some biotin-based confirmatory assays used in clinical laboratories.
4. Collect a first-morning, midstream urine sample.
5. Freeze the sample promptly per the lab's instructions and ship according to their protocol; most labs require frozen or cold-chain shipping to preserve analyte stability.

Medications and other confounders to disclose

Some medications are known to alter organic acid patterns. Valproic acid, for example, is recognized to affect fatty-acid and organic-acid metabolism in ways that can produce patterns overlapping with certain inherited disorders; the exact analyte affected should be confirmed against the performing lab's interpretive guidance rather than assumed. Antibiotics taken within the prior two weeks can substantially change gut microbial metabolite markers. Any current medication should be listed on the requisition so the interpreting clinician can flag markers that may be confounded rather than pathological.

Reading patterns, not single numbers

A single abnormal marker rarely justifies a clinical conclusion on its own. Clusters are more informative:

• Fatty-acid oxidation cluster. Adipic, suberic, and sebacic acids rise together with both dietary ketosis and true fatty-acid oxidation disorders. 3-hydroxyglutaric acid is a useful discriminator: it is not expected to rise with diet alone, so its presence alongside the other markers shifts suspicion toward glutaric acidemia type I or riboflavin deficiency rather than diet.
• Neurotransmitter metabolism cluster. Homovanillic acid (HVA) and vanillylmandelic acid (VMA) track dopamine and norepinephrine breakdown; kynurenic and quinolinic acid track tryptophan metabolism through the kynurenine pathway. Dietary tryptophan, supplemental 5-HTP, and melatonin all shift these markers, so recent supplement use should be documented before interpreting them as evidence of neuroinflammation or catecholamine dysfunction.

What is established, what is plausible, and what is not established

Established: Fasting duration and macronutrient composition materially change multiple organic acid analytes, sometimes enough to mimic an inherited metabolic disorder on a single test. Methylmalonic acid, xanthurenic acid, and FIGLU are recognized functional markers of B12, B6, and folate status respectively, with biochemical mechanisms that are well described. GC-MS is the standard analytic method for this panel, and creatinine normalization is standard practice for interpreting concentration-dependent results.

Plausible but not firmly established: The specific "optimal" numeric targets used in functional medicine practice, distinct from a laboratory's own validated reference range, have not been shown in controlled outcome trials to predict clinical benefit better than standard ranges. Some marker-diet fold-change figures circulating in patient-facing material could not be confirmed against a verifiable primary source for this draft and should be treated as approximate until a specific citation is confirmed.

Not established: Urinary arabinose and tartaric acid as validated diagnostic markers of candida or fungal overgrowth. Precise retest intervals presented as universal rules; actual intervals depend on the analyte, the clinical question, and the performing laboratory's protocol.

When this test is not the right next step

If there is concern about an acute metabolic crisis, especially in an infant or child with vomiting, lethargy, poor feeding, or unexplained acidosis, that is an emergency evaluation, not a scheduled outpatient organic acids panel. Urgent inborn-error-of-metabolism workups use different, time-sensitive protocols and should go through emergency or genetics services rather than a routine functional-medicine test order.

Frequently asked questions

Note on sources

This draft removed several precise numeric claims (fold-changes, sensitivity and specificity percentages, exact citation identifiers) that appeared in the earlier version of this article because they could not be confirmed against a verifiable primary source at the time of this rewrite. The underlying biochemical relationships described above (fasting shifting fuel source, ketogenic diet raising ketone-related markers, MMA as a B12 marker, and similar) reflect well-established metabolic biochemistry, but specific numbers attributed to named journals should be independently verified before being republished or cited to a patient. Readers and reviewers with access to the primary literature are encouraged to confirm and reinsert exact figures where they can be verified.